Advertisement

Israel's Brainsway wins CE Mark approval to treat chronic pain with its Deep TMS neurostimulation implants, marking the 6th indication for the devices.

MassDevice.com Regulatory Roundup

 Brainsway wins CE Mark approval for chronic pain brain-stim implant
Israeli device maker Brainsway won CE Mark approval in the European Union for its Deep TMS neurostimulation device for treatment of chronic, or neuropathic, pain.

The new approval marks the 6th CE Mark application for the Deep TMS device, joining clinical depression, bi-polar disorder, schizophrenia (negative symptoms), Parkinson's diseases and post-traumatic stress disorder.
Read more

Advertisement
Advertisement